diabetic retinopathy articles & resources on Made-in-China.com

OCT Systems Sales ‘to Double’ to €1bn by 2019

Nov 5, 2015

Despite the apparent saturation of optical coherence tomography systems in the ophthalmology markets of developed countries, the distinct OCT market for healthcare and life science sectors is still expected to grow from around €500 ...

Tags: OCT Systems, healthcare sectors, life science sectors

Cancer Diagnostics to Drive Coherence Tomography Market Growth

Nov 5, 2015

The emergence of applications in cancer diagnostics, cardiology and gastroenterology will help drive the market for clinical optical imaging to $2 billion by the end of the decade. That’s according to a new market report from the ...

Tags: Cancer Diagnostics, optical technologies, ultrasound technologies

OCT Market to Grow Rapidly From 2013 to 2019

Oct 6, 2014

Despite the apparent saturation of optical coherence tomography systems in the ophthalmology markets of developed countries, the distinct OCT market for healthcare and life science sectors is still expected to grow from around €500 ...

Tags: OCT Systems, Electronics

Research Is Under Way to Develop New Techniques for Detecting Diabetic Retinopathy

Jan 22, 2014

Research is under way to develop new techniques for detecting diabetic retinopathy at early onset with the hope of improving prevention and treatment of this major cause of blindness. Diabetic retinopathy is a common complication of ...

Tags: Health, Medicine

Unilife Has Announced The Signing of an Agreement

Dec 18, 2013

Unilife, a medical device and technology company, has announced the signing of an agreement with a global pharmaceutical company seeking to use the Unilife Ocu-ject ocular drug delivery system to deliver a target injectable therapy into the ...

Tags: Unilife, medical device

Lumenis Obtains FDA and Japanese Approval for Multi-Spot Laser Photocoagulation

Nov 19, 2013

Lumenis has obtained the US Food and Drug Administration (FDA) and the Japanese Ministry of Health, Labour and Welfare (MHLW) approvals for its Array LaserLink pattern scanning device for multi-spot laser photocoagulation for use during ...

Tags: Lumenis, Laser Treatment

a New Method for The Diagnosis of Retinal Microaneurysm Was Ethan Launched

Jun 13, 2013

The Hebrew University of Jerusalem’s Yissum Research Development Company has developed a novel method to diagnose retinal micro-aneurysms that pose a high risk for leakage, a primary cause of diabetic retinopathy. The novel method ...

Tags: Yissum, Retinal Micro-Aneurysms

A Number of Steps Can Help Prevent Disease of Your Summer in Summer

May 15, 2013

Summer sun increases the risk of age-related macular degeneration, the leading cause of blindness in adults. A number of steps can help prevent that disease, as well as your risk of developing cataracts, diabetic retinopathy, and glaucoma. ...

Tags: Eyes, Summer, Health&Medicine

Psivida Has Announced The Availability of The Sustained Release Pharmaceutical Product

May 9, 2013

pSivida has announced the availability of the sustained release pharmaceutical product indicated for the treatment of chronic diabetic macular edema (DME), Iluvien, in Germany. Alimera Sciences, pSivida's licensee, has reported the ...

Tags: pSivida Iluvien, Medicine

CeQur Has Reported Its PaQ Insulin Delivery Device Initial Study Data

Mar 6, 2013

CeQur has reported its PaQ insulin delivery device initial study data at the 6th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Paris, France. The discreet, wearable CE-marked device, which comprises ...

Tags: CeQur, PaQ insulin delivery device, insulin infuser reservoir

Regeneron and Bayer Have Started a New Phase 3 VEGF Trap-Eye in Vision Impairment

Feb 21, 2013

Regeneron Pharmaceuticals and Bayer HealthCare have started a new Phase 3 VEGF Trap-Eye In Vision Impairment Due to DME (VIVID EAST-DME) trial of its Eylea (aflibercept) injection. Eylea, which is formulated as an iso-osmotic solution for ...

Tags: Regeneron Pharmaceuticals, Bayer HealthCare

US Patents and Trademarks Has Issued Notice of Allowance for DME Drug Optina Patent

Jan 2, 2013

The US office of patents and trademarks has issued notice of allowance to Ampio Pharmaceuticals for diabetic macular edema (DME) drug Optina patent. The company has also received similar patent from the Canadian Intellectual Property ...

Tags: Ampio, allowance for DME drug, Optina patent

Diagnos Initiates a New Screening Program for The Prevention of Diabetic Retinopathy

Dec 17, 2012

Diagnos has initiated a new screening program for the prevention of diabetic retinopathy and vision loss in Canada. Under the new 'BEAT IT IN A BLINK' program, the company will make use of its proprietary Computer Assisted Retinal ...

Tags: Diagnos, screening program, diabetic retinopathy, vision loss

Diopsys Has Developed a New Office-Based Nova-Pattern Electroretinography (PERG) Test

Dec 14, 2012

Diopsys, a medical instrumentation company, has developed a new office-based Nova-Pattern electroretinography (PERG) test. By utilizing visual evoked potential technology, the test measures the function of the inner retinal cells of the ...

Tags: diopsys, medical instrumentation, PERG test, inner retinal cells

diabetic retinopathy

Related Products